Chairman, Co-Founder & Chief Executive Officer

Dr. Vijay Chandru (PhD, MIT 1982) is an academic entrepreneur named as the "Technology Pioneer" by World Economic Forum in 2006. Chandru is founder of Strand Life Sciences and currently serves as its Chairman and Chief Executive Officer. Chandru's academic career has spanned over two decades at Purdue University and the Indian Institute of Science.

Chandru is the recipient of several awards and honors: Fellow of Indian Academy of Sciences (1996), MCIT Dewang Mehta Award for Innovation in IT (2001), UGC Hari Om Trust award for "Science and Society" (2003), the President's Medal of INFORMS in 2006, distinguished Alumni award by the MIT India Program in 2007, and was recognized as the Biospectrum Biotech Entrepreneur of 2007.

Chandru is the elected President (2009-2012) of Association of Biotech led Enterprises (ABLE), the apex trade body representing the Indian Biotech industry.

Managing Director, Sequoia Capital India

Sandeep Singhal is a Managing Director with Sequoia Capital India. Prior to joining Sequoia Capital India, Sandeep was with WestBridge Capital Partners. Earlier, Sandeep worked at BCG, where he advised several mid-market Indian companies on their product and marketing strategies. Prior to BCG, Sandeep worked with Hindustan Lever Limited (HLL), where he was instrumental in eleven product launches targeting Indian consumer segments that have provided significant contribution to the company's business. Sandeep serves on the board of the Internet and Mobile Association of India (IAMAI).

Sandeep received an MBA with distinction from IIM Ahmedabad, an MS in molecular simulation from the University of Illinois, and a B. Tech. in Chemical Engineering from IIT Delhi.

Managing Director and CEO, UTI Venture Funds Management Company Limited

Raja founded UTI Ventures in the Year 2000. He has played a pivotal role in building an experienced management team and forging significant LP relationships for the firm. He brings over two decades of experience and an impressive network in Indian capital markets. Raja leads the firm's fund raising efforts and guides the team in concluding investments and facilitating exits. He actively works with entrepreneurs and represents our funds on the boards of several portfolio companies. Raja also served as Executive Director of UTI Mutual Fund, one of India's largest mutual fund houses. Prior to founding UTI Ventures, Raja was Regional Director of the Securities and Exchange Board of India (SEBI - India's capital market regulator) and also served as Director of five Indian Stock Exchanges. Earlier, Raja was a senior officer in the Indian Civil Services.

He holds a Masters degree and an M Phil in Science and is a graduate of the Advanced Management Program at Harvard Business School.

Founder and Chairman at LimberLink Technologies, Co- Founder - Stand Life Sciences

Dr. V. Vinay is a founder and Chairman of LimberLink Technologies. Prior to this he was the Group Chief Technologist for Geodesic Ltd. He has co-founded two successful startups, PicoPeta Simputer and Strand Life Sciences. PicoPeta was acquired by Geodesic in 2006. He serves on the board of Strand Life Sciences.

Vinay was a professor at the India Institute of Science for over a decade from 1995 to 2005. He is currently an adjunct professor at the Chennai Mathematical Institute (CMI). He has a wide range of interests in mathematical aspects of computer science, especially in Complexity Theory, Algorithms, and Data Mining.

Vinay is a recipient of the prestigious Sir C.V. Raman Award by the government of Karnataka for Excellence in Engineering Research in 2001. He is a winner of the Dewang Mehta Award for Innovation in Informatics for his role in developing the Simputer. He currently serves as a President of the Indian Association for Research in Computing Science (IARCS).

President & CEO-MediBIC Group, President-MediBIC Pharma, President-Asia Private Equity Capital, Executive Director-Site Quality Co. Ltd

Dr. Hashimoto is a graduate of Osaka University Medical School. Following his postdoctoral research at Harvard University Medical School, he became an Adjunct Associate Professor at the University of Pennsylvania. He is also experienced Senior Director of the Institute of Immunology, Syntex, Japan, Director Biotechnology, Department of Roche (US) and Director of Molecular Biology Department for the Tsukuba Laboratory of Nippon Glaxo Ltd (currently GlaxoSmithKline K.K.). During Nippon Glaxo, he was involved in PGx project planning.

In 2000, he founded MediBIC and is the President and CEO of the company. He is also on the board of several Asian biotech companies, serving as the Board of Directors.